Stem Cell Revival: The 1990s are Back
By New Scientist,
New Scientist
| 04. 30. 2014
"SINCE what works in sheep is likely to be possible in humans, we are suddenly propelled right past the imagined techniques of Brave New World." That was how New Scientist greeted the news, in March 1997, of the creation of Dolly the cloned sheep.
It has taken longer than expected. More than 17 years later, what worked in sheep finally appears to be working in humans (see "Insulin-making cells created by Dolly-cloning method"). This is a potentially major medical breakthrough, but no longer feels as challenging as it once did. In fact, after endless hope, hype and failure, it is hard to feel there is anything brave or new in this line of research.
To say stem cell science has a chequered past would be an understatement. Those with long memories will recall that South Korea's fallen stem-cell hero Woo Suk Hwang falsely claimed to have replicated the Dolly technique in humans in 2005.
Controversy has dogged the field ever since. Because the Dolly technique involves the destruction of human embryos, its ethical dimensions have been...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...